Biomedica Immunoassays

First FGF23 (C-terminal) ELISA, CE marked!
for both serum and plasma samples

High Sensitive FREE soluble RANKL ELISA
Measurable concentrations in healthy subjects

Bone Metabolism

Biomedica offers ELISA kits for the determination of biomarkers of bone metabolism. Our assay portfolio ranges from Osteoprotegerin and a highly sensitive free soluble RANKL assay to biomarkers of the Wnt signaling pathway such as Sclerostin and DKK-1.

Our ELISA assays are fully validated to ensure high quality and reproducibility. Every kit includes five to seven calibrators and one to two controls in a human serum matrix, thus allowing researchers to collect biologically reliable data.

Cardiovascular

Biomedica offers ELISA kits for the determination of biomarkers in cardiovascular disease. Our assay portfolio ranges from natriuretic peptides, such as NT-proBNP and NT-proANP, to the Endothelins including Big ET and ET. Osteoprotegerin, a regulator of bone metabolism has evolved to a biomarker of cardiovascular disease.

Our ELISA assays are fully validated to ensure high quality and reproducibility. Every kit includes five to six calibrators and one to two controls in a human serum matrix, thus allowing researchers to collect biologically reliable data.

Oxidative Stress

Biomedica's oxidative stress product line covers biomarkers for risk stratification (OxyStat and MDA-oxidized LDL) and one biomarker to determine the severity of disease (oLAB - anti oxidized LDL autoantibodies).

Our ELISA assays include six calibrators and one to two controls in human serum matrix, thus allowing researchers to collect biologically reliable data.

Nephrology & Transplant

Biomedica offers ELISA kits for the determination of biomarkers in kidney disease. Our assay portfolio ranges from FGF23 (fibroblast growth factor 23) to Endostatin. The C4d antibody complements this product line as marker of humoral transplant rejection.

Our ELISA assays are fully validated to ensure high quality and reproducibility. Every kit includes six or seven calibrators and one or two controls in a human serum matrix, thus allowing researchers to collect biologically reliable data.  

Lyme Disease

Biomedica offers ELISA kits for the diagnostic screening of Lyme Borreliosis - Borrelia recombinant IgG ELISA and Borrelia recombinant IgM ELISA. The combination of antigens used in both Borrelia assays detect antibodies directed against the different Borrelia species, pathogenic for humans, including B. burgdorferi senso strictu.

Our Borrelia assays are fully validated ELISAs to ensure high quality and reproducibility of the results. Results are further confirmed by regular participation in external quality control circles. Each kit includes ready to use reagents and can process serum, plasma, and liquor samples.

Other Products

Biomedica is proud to be the exclusive partner of Glycotechnica offering Glycomics - Simplified Glycoanalysis in Europe. This new technology - based on LecChip™ (Lectin microarrays) - enables quick and accurate glycan profiling for any complex glycans, even for mixtures.

Additionally, Biomedica offers the EZ4U, a non-radioactive cell proliferation and cytotoxicity assay, as well as the RFS, reagents for the elimination of rheumatoid factor in serum and plasma.

FGF23 (C-terminal) ELISA
New: CE marked!

Biomedica launches first CE marked FGF23 (C-terminal) ELISA assay in Europe and Asia. This assay specifically detects both intact and C-terminal FGF23 in human serum and plasma.

Read more...

Biomedica @ ECTS & IBMS
Rotterdam, April 25-28, 2015

Biomedica presents first CE marked FGF23 ELISA at the 4th joint meeting of ECTS and IBMS. Come and visit us at booth # 6 of our partner IDS and learn more about Biomedica and our products.

Read more...

FREE soluble RANKL ELISA
3rd generation - CE marked

Highly sensitive ELISA for measurable concentrations of free soluble umcomplexed RANKL in healthy subjects.

Read more...